Cimzia Home Injection Experience
For people living with rheumatoid arthritis and Crohn’s Disease, finally there is relief. The Cimzia home injection experience by UCB is the first of its kind not only designed for these patients — it was designed with them — and in response to their individual needs and challenges.
After FDA approval in 2009,
Cimzia was also recognized
by the Arthritis Foundation
for its ease-of-use.
Smart worked with UCB and OXO, the brand behind the Good Grips line, to completely rethink the self-injection process. While the business goal was to maximize medication adherence for our client, we knew putting patients in control of their own medication would require more than designing a successful tool. It would also need carefully considered communication design.
To get there, we were guided by the belief that people don’t want to be constantly reminded that they’re sick. This led us to our vision of giving patients more “good days” through an experience that’s simple, quick and lets people get back to enjoying everyday life.
Throughout the project, our design team was in close communication with six extreme RA patients. We followed their daily routines and shadowed them as they struggled with everyday challenges. With our research in hand, we delved deep into ergonomics and biomechanics since the product would need to work with a wide range of dexterity levels.
Approved by the FDA in May 2009, the new syringe has gained the trust of even the most severe arthritis patients. The design allows patients to exert an average of 48 percent more force despite weakness in their hands and joints that are sensitive to pressure. It’s also received the “Ease-of-Use” Commendation from the Arthritis Foundation.